The House Oversight Committee's ongoing investigation into Jeffrey Epstein's files and network has driven recent trader focus on potential congressional testimony, following the Epstein Files Transparency Act's implementation and the release of millions of DOJ records in late 2025 and early 2026. Closed-door sessions have already featured Commerce Secretary Howard Lutnick addressing his past ties, while a May 12 field hearing in Palm Beach allowed survivors to provide public accounts of abuses and systemic failures. Scheduled appearances include Bill Gates in June, former Attorney General Pam Bondi, and prior depositions from figures such as Ghislaine Maxwell and the Clintons, with additional subpoenas targeting associates like Leon Black and Kathryn Ruemmler. These developments reflect partisan dynamics in document releases, witness compliance, and procedural timelines that could shape which individuals ultimately appear before lawmakers.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour$61,053 Vol.
30 juin 2026
Elon Musk
33%
L’ex-prince Andrew
12%
Donald Trump
7%
Lord Peter Mandelson
6%
Ghislaine Maxwell
4%
$61,053 Vol.
Elon Musk
$1,090 Vol.
33%
L’ex-prince Andrew
$1,150 Vol.
12%
Donald Trump
$638 Vol.
7%
Lord Peter Mandelson
$2,490 Vol.
6%
Ghislaine Maxwell
$5,775 Vol.
4%
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.The House Oversight Committee's ongoing investigation into Jeffrey Epstein's files and network has driven recent trader focus on potential congressional testimony, following the Epstein Files Transparency Act's implementation and the release of millions of DOJ records in late 2025 and early 2026. Closed-door sessions have already featured Commerce Secretary Howard Lutnick addressing his past ties, while a May 12 field hearing in Palm Beach allowed survivors to provide public accounts of abuses and systemic failures. Scheduled appearances include Bill Gates in June, former Attorney General Pam Bondi, and prior depositions from figures such as Ghislaine Maxwell and the Clintons, with additional subpoenas targeting associates like Leon Black and Kathryn Ruemmler. These developments reflect partisan dynamics in document releases, witness compliance, and procedural timelines that could shape which individuals ultimately appear before lawmakers.
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Marché ouvert : Feb 2, 2026, 2:59 PM ET
Volume
$61,053Date de fin
30 juin 2026Marché ouvert
Feb 2, 2026, 2:59 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.The House Oversight Committee's ongoing investigation into Jeffrey Epstein's files and network has driven recent trader focus on potential congressional testimony, following the Epstein Files Transparency Act's implementation and the release of millions of DOJ records in late 2025 and early 2026. Closed-door sessions have already featured Commerce Secretary Howard Lutnick addressing his past ties, while a May 12 field hearing in Palm Beach allowed survivors to provide public accounts of abuses and systemic failures. Scheduled appearances include Bill Gates in June, former Attorney General Pam Bondi, and prior depositions from figures such as Ghislaine Maxwell and the Clintons, with additional subpoenas targeting associates like Leon Black and Kathryn Ruemmler. These developments reflect partisan dynamics in document releases, witness compliance, and procedural timelines that could shape which individuals ultimately appear before lawmakers.
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Volume
$61,053Date de fin
30 juin 2026Marché ouvert
Feb 2, 2026, 2:59 PM ETResolver
0x65070BE91...The House Oversight Committee's ongoing investigation into Jeffrey Epstein's files and network has driven recent trader focus on potential congressional testimony, following the Epstein Files Transparency Act's implementation and the release of millions of DOJ records in late 2025 and early 2026. Closed-door sessions have already featured Commerce Secretary Howard Lutnick addressing his past ties, while a May 12 field hearing in Palm Beach allowed survivors to provide public accounts of abuses and systemic failures. Scheduled appearances include Bill Gates in June, former Attorney General Pam Bondi, and prior depositions from figures such as Ghislaine Maxwell and the Clintons, with additional subpoenas targeting associates like Leon Black and Kathryn Ruemmler. These developments reflect partisan dynamics in document releases, witness compliance, and procedural timelines that could shape which individuals ultimately appear before lawmakers.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes